Valuation Merck KGaA

Stocks

Market Closed - Xetra Other stock markets 09:05:01 15/06/2026 pm IST			After hours 11:40:02 pm
132.70 ^EUR	-0.41%		132.62	-0.06%

09/06	Merck Announces Management Appointments	CI
01/06	MERCK KGAA : Receives a Buy rating from JP Morgan	ZD

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	98,695	78,651	62,651	60,825	53,304	57,934	-	-
Change	-	-20.31%	-20.34%	-2.91%	-12.37%	8.69%	-	-
Enterprise Value (EV) ¹	1,07,596	86,979	70,610	68,609	62,533	65,463	63,558	61,676
Change	-	-19.16%	-18.82%	-2.83%	-8.86%	4.69%	-2.91%	-2.96%
P/E Ratio	32.3x	23.6x	22.2x	21.9x	20.4x	22.5x	19.5x	17.4x
PBR	4.63x	3.03x	2.35x	2.03x	1.86x	1.89x	1.77x	1.65x
PEG	-	2.68x	-1.5x	-14.21x	-3.34x	-16.85x	1.3x	1.4x
Capitalization / Revenue	5.01x	3.54x	2.98x	2.88x	2.53x	2.75x	2.63x	2.49x
EV / Revenue	5.47x	3.91x	3.36x	3.24x	2.96x	3.11x	2.88x	2.65x
EV / EBITDA	17.6x	12.7x	12x	11.3x	10.2x	11.1x	10x	9.04x
EV / EBIT	25.7x	19.4x	19.6x	18.8x	17.4x	18.1x	15.9x	13.9x
EV / FCF	30.3x	31.9x	36.9x	23.8x	26.6x	23.3x	21.1x	18.9x
FCF Yield	3.3%	3.14%	2.71%	4.2%	3.75%	4.29%	4.73%	5.3%
Dividend per Share ²	1.85	2.2	2.2	2.2	2.2	2.328	2.416	2.515
Rate of return	0.81%	1.22%	1.53%	1.57%	1.79%	1.75%	1.81%	1.89%
EPS ²	7.03	7.65	6.49	6.39	6	5.92	6.821	7.654
Distribution rate	26.3%	28.8%	33.9%	34.4%	36.7%	39.3%	35.4%	32.9%
Net sales ¹	19,687	22,232	20,993	21,156	21,102	21,041	22,057	23,284
EBITDA ¹	6,103	6,849	5,879	6,072	6,109	5,922	6,331	6,824
EBIT ¹	4,179	4,474	3,609	3,645	3,601	3,609	3,990	4,428
Net income ¹	3,055	3,326	2,824	2,777	2,608	2,554	2,929	3,271
Net Debt ¹	8,902	8,328	7,959	7,784	9,229	7,529	5,624	3,741
Reference price ²	227.00	180.90	144.10	139.90	122.60	133.25	133.25	133.25
Nbr of stocks (in thousands)	4,34,778	4,34,778	4,34,778	4,34,778	4,34,778	4,34,778	-	-
Announcement Date	03/03/22	02/03/23	07/03/24	06/03/25	05/03/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
MERCK KGAA	22.51x	3.11x	11.05x	1.75%	6.71TCr
MERCK & CO., INC.	53.11x	4.94x	20.09x	2.81%	29TCr
KYOWA KIRIN CO., LTD.	15.56x	1.94x	6.68x	2.87%	784.46Cr
SK BIOPHARMACEUTICALS CO., LTD.	22.12x	6.62x	18.11x	-.--%	454.14Cr
YUHAN CORPORATION	42.86x	2.43x	29.57x	0.72%	379.78Cr
BETTA PHARMACEUTICALS CO., LTD.	28.8x	5.51x	15.75x	-	334.87Cr
SUPERNUS PHARMACEUTICALS, INC.	102.49x	-	-	-.--%	257.75Cr
Average	41.06x	4.09x	16.87x	1.36%	5.47TCr
Weighted average by Cap.	46.64x	4.56x	18.25x	2.55%